IL155718A0 - Novel medicament compositions based on tiotropium salts and on salmeterol salts - Google Patents

Novel medicament compositions based on tiotropium salts and on salmeterol salts

Info

Publication number
IL155718A0
IL155718A0 IL15571801A IL15571801A IL155718A0 IL 155718 A0 IL155718 A0 IL 155718A0 IL 15571801 A IL15571801 A IL 15571801A IL 15571801 A IL15571801 A IL 15571801A IL 155718 A0 IL155718 A0 IL 155718A0
Authority
IL
Israel
Prior art keywords
salts
salmeterol
tiotropium
compositions based
medicament compositions
Prior art date
Application number
IL15571801A
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of IL155718A0 publication Critical patent/IL155718A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Abstract

Drug compositions containing one or more tiotropium salts and one or more salmeterol salts, are new. Drug compositions containing one or more tiotropium salts and one or more salmeterol salts, are new. The salts can be present in the form of enantiomers, enantiomer mixtures or racemates as well as in the form of solvates or hydrates. The compositions may also contain a pharmaceutical adjuvant. ACTIVITY : Antiasthmatic. MECHANISM OF ACTION : Anticholinergic; beta -mimetic.
IL15571801A 2000-11-13 2001-11-09 Novel medicament compositions based on tiotropium salts and on salmeterol salts IL155718A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10056104A DE10056104A1 (en) 2000-11-13 2000-11-13 Drug compositions useful for treatment of respiratory diseases, especially asthma and chronic obstructive pulmonary disease comprises tiotropium salts and salmeterol salts
PCT/EP2001/012962 WO2002038154A1 (en) 2000-11-13 2001-11-09 Novel medicament compositions based on tiotropium salts and on salmeterol salts

Publications (1)

Publication Number Publication Date
IL155718A0 true IL155718A0 (en) 2003-11-23

Family

ID=7663071

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15571801A IL155718A0 (en) 2000-11-13 2001-11-09 Novel medicament compositions based on tiotropium salts and on salmeterol salts
IL155718A IL155718A (en) 2000-11-13 2003-05-01 Medicament compositions based on tiotropium salts and on salmeterol salts

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155718A IL155718A (en) 2000-11-13 2003-05-01 Medicament compositions based on tiotropium salts and on salmeterol salts

Country Status (32)

Country Link
EP (3) EP1335728B1 (en)
JP (2) JP4282322B2 (en)
KR (2) KR100886094B1 (en)
CN (1) CN1678318A (en)
AT (2) ATE362761T1 (en)
AU (3) AU2002227910B2 (en)
BG (1) BG107781A (en)
BR (1) BR0115226A (en)
CA (1) CA2429012A1 (en)
CY (1) CY1106774T1 (en)
CZ (1) CZ20031444A3 (en)
DE (3) DE10056104A1 (en)
DK (2) DK1335728T3 (en)
EA (1) EA007904B1 (en)
EC (1) ECSP034571A (en)
EE (1) EE200300228A (en)
ES (2) ES2240549T3 (en)
HR (1) HRP20030378A2 (en)
HU (1) HUP0301447A3 (en)
IL (2) IL155718A0 (en)
MX (1) MXPA03004164A (en)
NO (1) NO20032111L (en)
NZ (1) NZ526400A (en)
PL (1) PL205330B1 (en)
PT (2) PT1514546E (en)
RS (2) RS50286B (en)
SG (1) SG167657A1 (en)
SI (2) SI1514546T1 (en)
SK (2) SK286950B6 (en)
UA (1) UA74853C2 (en)
WO (1) WO2002038154A1 (en)
ZA (1) ZA200302921B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (en) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa NEW DERIVATIVES OF QUINUCLIDINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.
US7214687B2 (en) 1999-07-14 2007-05-08 Almirall Ag Quinuclidine derivatives and medicinal compositions containing the same
EP1523976A3 (en) * 1999-11-23 2005-06-22 Glaxo Group Limited Pharmaceutical formulations of salmeterol
MXPA04002401A (en) * 2001-09-14 2004-05-31 Boehringer Ingelheim Pharma Novel medicaments for inhalation.
DE10214263A1 (en) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA suspension formulations containing an anticholinergic
US7311894B2 (en) 2002-03-28 2007-12-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations containing an anticholinergic
US7244415B2 (en) 2002-03-28 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg HFA suspension formulations of an anhydrate
US7250426B2 (en) 2002-11-29 2007-07-31 Boehringer Ingelheim Pharma Gmbh & Co Kg Tiotropium-containing pharmaceutical combination for inhalation
DE10256080A1 (en) * 2002-11-29 2004-06-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Combination medicinal product for inhalation containing tiotropium
CN1726038A (en) * 2002-12-16 2006-01-25 贝林格尔英格海姆法玛两合公司 Tiotropium containing HFC solution formulations
DE10351663A1 (en) * 2002-12-20 2004-07-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Stable, accurately dosable inhalable powder medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium, specific form of salmeterol xinafoate and auxiliary
DE10345065A1 (en) * 2003-09-26 2005-04-14 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosol formulation for inhalation containing an anticholinergic
WO2005042526A1 (en) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Method for producing tiotropium salts, tiotropium salts and pharmaceutical formulations, containing the same
JP5165245B2 (en) * 2003-11-03 2013-03-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Novel tiotropium salt, process for its production and pharmaceutical composition containing tiotropium salt
ES2257152B1 (en) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. COMBINATIONS THAT INCLUDE ANTIMUSCARINIC AGENTS AND BETA-ADRENERGIC AGONISTS.
EP1761279A1 (en) * 2004-05-31 2007-03-14 Laboratorios Almirall, S.A. Combinations comprising antimuscarinic agents and pde4 inhibitors
CA2606549A1 (en) 2005-05-02 2006-11-09 Boehringer Ingelheim International Gmbh Crystalline forms of tiotropium bromide
JP2009504603A (en) * 2005-08-06 2009-02-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Method of treating dyspnea by administering a combination of tiotropium salt and salmeterol salt
ES2298049B1 (en) 2006-07-21 2009-10-20 Laboratorios Almirall S.A. PROCEDURE FOR MANUFACTURING BROMIDE OF 3 (R) - (2-HIDROXI-2,2-DITIEN-2-ILACETOXI) -1- (3-PHENOXIPROPIL) -1-AZONIABICICLO (2.2.2) OCTANO.
EP2100599A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
EP2100598A1 (en) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
US20120220557A1 (en) * 2011-02-17 2012-08-30 Chiesi Farmaceutici S.P.A. Liquid propellant-free formulation comprising an antimuscarinic drug
EP2510928A1 (en) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium for use in improving the quality of sleep in respiratory patients
WO2013127738A1 (en) * 2012-02-28 2013-09-06 Boehringer Ingelheim International Gmbh Novel propellant-gas-containing tiotropium formulation
WO2015065222A1 (en) * 2013-10-28 2015-05-07 Шолекс Девелопмент Гмбх Pharmaceutical inhaled drug with micronized tiotropium bromide as active ingredient for the treatment of bronchial asthma and chronic obstructive pulmonary disease and method for producing same
TW201835041A (en) 2017-02-17 2018-10-01 印度商托仁特生技有限公司 Compounds with Beta-Adrenergic Agonist and Antimuscarinic Activity
WO2019142214A1 (en) * 2018-01-19 2019-07-25 Cipla Limited Pharmaceutical composition comprising tiotropium for inhalation
CN116173025A (en) * 2018-07-26 2023-05-30 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and indacaterol salt, and preparation method and application thereof
CN111971034A (en) * 2018-07-26 2020-11-20 四川海思科制药有限公司 Aerosol pharmaceutical composition containing glycopyrronium salt and preparation method and application thereof
US11826382B2 (en) 2020-05-01 2023-11-28 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
US11642372B2 (en) 2020-05-01 2023-05-09 Tygrus, LLC Therapeutic material with low pH and low toxicity active against at least one pathogen for addressing patients with respiratory illnesses
WO2022119661A1 (en) * 2020-12-04 2022-06-09 Tygrus, LLC THERAPEUTIC MATERIAL WITH LOW pH AND LOW TOXICITY ACTIVE AGAINST AT LEAST ONE PATHOGEN FOR ADDRESSING PATIENTS WITH RESPIRATORY ILLNESSES

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE283033T1 (en) * 1998-07-24 2004-12-15 Jago Res Ag MEDICAL AEROSOL FORMULATIONS
DE19835346A1 (en) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Two-part capsule for pharmaceutical preparations for powder inhalers
DE19847971A1 (en) * 1998-10-17 1999-09-02 Schiering Filter fire occurrence prevention method
DE19847970A1 (en) * 1998-10-17 2000-04-20 Boehringer Ingelheim Pharma Stable concentrated liquid formulation of inhalable drug, e.g. formoterol or salbutamol, in solution or suspension medium, used after dilution for treatment of respiratory disorders by inhalation
DE19921693A1 (en) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Pharmaceutical composition for treating respiratory disorders, e.g. asthma, comprises combination of anticholinergic and beta-mimetic agents having synergistic bronchospasmolytic activity and reduced side-effects
DE19961300A1 (en) * 1999-12-18 2001-06-21 Asta Medica Ag Storage system for medicinal products in powder form and inhaler equipped with them

Also Published As

Publication number Publication date
ATE362761T1 (en) 2007-06-15
UA74853C2 (en) 2006-02-15
SK7412003A3 (en) 2003-10-07
WO2002038154A1 (en) 2002-05-16
DE50105729D1 (en) 2005-04-28
RS20090105A (en) 2009-07-15
EP1514546B1 (en) 2007-05-23
ES2240549T3 (en) 2005-10-16
DK1335728T3 (en) 2005-04-18
ATE291428T1 (en) 2005-04-15
EP1514546A1 (en) 2005-03-16
HUP0301447A3 (en) 2007-10-29
RS50286B (en) 2009-09-08
JP2005068163A (en) 2005-03-17
AU2791002A (en) 2002-05-21
ES2287629T3 (en) 2007-12-16
DK1514546T3 (en) 2007-09-24
IL155718A (en) 2010-06-30
SI1335728T1 (en) 2005-08-31
CY1106774T1 (en) 2012-05-23
DE10056104A1 (en) 2002-05-23
PT1514546E (en) 2007-06-15
HRP20030378A2 (en) 2005-04-30
BR0115226A (en) 2003-10-07
EA200300503A1 (en) 2004-12-30
KR20030065509A (en) 2003-08-06
ZA200302921B (en) 2004-04-19
AU2007202303B2 (en) 2010-01-21
JP4282594B2 (en) 2009-06-24
DE50112535D1 (en) 2007-07-05
EP1808174A1 (en) 2007-07-18
CZ20031444A3 (en) 2003-08-13
MXPA03004164A (en) 2005-08-16
EA007904B1 (en) 2007-02-27
PL205330B1 (en) 2010-04-30
NO20032111L (en) 2003-07-08
KR100940752B1 (en) 2010-02-11
CA2429012A1 (en) 2002-05-16
ECSP034571A (en) 2003-06-25
EP1335728A1 (en) 2003-08-20
EP1335728B1 (en) 2005-03-23
PL365989A1 (en) 2005-01-24
NO20032111D0 (en) 2003-05-12
NZ526400A (en) 2005-09-30
CN1678318A (en) 2005-10-05
SG167657A1 (en) 2011-01-28
EE200300228A (en) 2003-10-15
SK286950B6 (en) 2009-08-06
YU35503A (en) 2006-05-25
SI1514546T1 (en) 2007-10-31
KR20080079701A (en) 2008-09-01
BG107781A (en) 2004-06-30
SK286939B6 (en) 2009-07-06
AU2007202303A1 (en) 2007-06-14
HUP0301447A2 (en) 2003-10-28
AU2002227910B2 (en) 2007-03-01
JP2004513146A (en) 2004-04-30
JP4282322B2 (en) 2009-06-17
PT1335728E (en) 2005-05-31
KR100886094B1 (en) 2009-02-27

Similar Documents

Publication Publication Date Title
AU2791002A (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
MY129512A (en) Novel medicament compositions, based on tiotropium bromide and salmeterol
PL355331A1 (en) Novel composition and use
IL151202A0 (en) Phenyl derivatives, a process for their praparation, pharmaceutical compositions containing them, a process for preparing the pharmaceutical compositions, and their use in therapy
AU2002227910A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
PT1349549E (en) Novel medicament compositions based on salts of tiotropium and on ciclesonide
WO2002032898A3 (en) Novel anticholinergics, method for the production thereof and use thereof as medicaments
WO2003009838A1 (en) Use of stilbene compounds in preparing medicaments for treating or preventing diabetes and diseases associated with retrovirus
WO2004055006A8 (en) Novel compounds having selective inhibiting effect at gsk3
WO2002036135A3 (en) Compositions for antitumour treatment containing ecteinascidin 743
TW200606147A (en) Indolyl derivatives as liver-X-receptor modulators
WO2000058293A3 (en) Glucokinase activators
HK1091121A1 (en) Substituted 2-aminotetralins for the treatment of depressions
HK1046374A1 (en) Camptothecin analogs and methods of preparation thereof
IL175127A0 (en) Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same
RS99804A (en) Novel compounds and their use
MY134167A (en) Biphenylcarboxamides useful as lipid lowering agents
HK1054026A1 (en) Substituted piperidines, medicaments containing these compounds, and methods for the production thereof.
WO2003087049A3 (en) Pharmaceutical combinations containing heterocyclic compounds and a novel anticholinergic agent
HUP0204360A3 (en) Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament and medicaments containing said compounds
NZ528164A (en) Use of flumazenil to produce a medicament for the treatment of cocaine dependency
TW200517146A (en) Novel composition
AU2001244999A1 (en) Naphthamide neurokinin antagonists for use as medicaments
MXPA03003752A (en) Novel medicament compositions.
DE60023321D1 (en) Composition against coccidiosis